IDO1 and colitis: Therefore, IDO-1 expression is increased in the gastrointestinal (GI) tract of both humans with inflammatory bowel disease (IBD) and animal models of colitis, due to overexpression of pro-inflammatory cytokines and over-activation of toll-like receptors [4–6].